VMC Members[close]

Login

Not yet a member?

Stay up to date with
the latest health news




Are you a Health Professional?

Read more detailed and referenced information written by Australian health professionals, make sure you select health professional in the signup form!

Hyperuricaemic Nephropathy (Gout, Purines and Interstitial Nephritis)


What is Hyperuricaemic Nephropathy?

Hyperuricaemic Nephropathy is a disease of the kidneys.There are three forms of renal disease associated with hyperuricaemia:1. Chronic hyperuricaemic nephropathy.2. Acute hyperuricaemic nephropathy.3. Uric acid stone formation: Nephrolithiasis (see Urinary Stone Disease).

Statistics on Hyperuricaemic Nephropathy

The prevalence of hyperuricaemia in Europe and the USA is approximately 5%.The presence of hyperuricaemia increases a patient's risk of developing gouty arthritis and crystal nephropathy. The exact risk of developing either of these conditions in the presence of elevated uric acid levels cannot be given as an absolute risk as hyperuricaemia can occur with varying severity.

Risk Factors for Hyperuricaemic Nephropathy

The central risk factor for the development of hyperuricaemic nephropathy is raised serum uric acid levels, or hyperuricaemia. Uric acid is the final breakdown product of purines within the body. Uric acid levels rise in the body as a result of either:a) increased production or b) decreased excretion. A. Increased production of uric acid:

  • Enzyme Defects: HGPRT (Hypoxanthine-Guanine-Phosphoribosyl Transferase) deficiency, Phosphoribosyl-pyrophosphate overactivity, Glucose-6-Phosphate deficiency.
  • Increased purine turnover: Myeloproliferative disorders (polycythaemia vera), Lymphoproliferative disorders (leukaemia), and certain forms of cancer.
  • Increased consumption in diet: offal, oily fish, beer.
B. Impaired Excretion of Uric Acid:
  • Chronic renal disease
  • Drugs therapy especially thiazide diuretics and aspirin
  • Hypertension
  • Hypothyroidism
  • Hyperparathyroidism
  • Increased lactic acid production from excessive exercise, alcohol or starvation.

    Progression of Hyperuricaemic Nephropathy

    Chronic Hyperuricaemic Nephropathy:The occurs in patients with a less severe but more protracted state of hyperuricaemia. The condition usually arises subtle, with an insidious decline of renal function that may progress to renal failure over many years.Acute Hyperuricaemic Nephropathy:This form of disease occurs mosst frequently in patient undergoing chemotherapy, in which cells are destroyed releasing large amounts of purine which is then metabolised to uric acid. The onset of symptoms is abrupt, resulting in oliguric renal failure over a short period. With appropriate therapy, the patient can be supported through their acute renal failure while uric acid levels are controlled with agents such as allopurinol.

    How is Hyperuricaemic Nephropathy Diagnosed?

    1. Establish baseline renal function - Bloods - Urea, Electrolytes and Creatinine, Serum uric acid.2. Investigate for obstruction - Intravenous pyelogram, renal ultrasonography.

    How is Hyperuricaemic Nephropathy Treated?

    1. Reduce Uric Acid concentration - Commence allopurinol immediately.2. Alkalinise urine - Give IV 1.26% sodium bicarbonate with acetazolamide (500mg PO stat, then 250mg tds).3. Monitor urea, creatinine and electrolytes and support through acute acute renal failure if present. Consider dialysis if renal failure cannot be controlled by conservative means. Expect recovery in 7-21 days. 4. Consider percutaneous nephrostomy if extrarenal obstruction exists and patient in complete ureteric obstruction. Stones may then pass spontaneously or be removed by urological surgeon.

    Hyperuricaemic Nephropathy References

    [1] Braunwald, Fauci, Kasper, Hauser, Longo, Jameson. Harrison's Principles of Internal Medicine. 15th Edition. McGraw-Hill. 2001.[2] Cotran, Kumar, Collins 6th edition. Robbins Pathologic Basis of Disease. WB Saunders Company. 1999.[3] Kumar P, Clark M. CLINICAL MEDICINE. WB Saunders 2002 Pg 545-549.[4] Longmore M, Wilkinson I, Torok E. OXFORD HANDBOOK OF CLINICAL MEDICINE. Oxford Universtiy Press. 2001.

    Drugs/Products Used in the Treatment of This Disease:


    Connect

    Sign up for free newsletter Sign up for free newsletters
    News RSS feeds Subscribe to RSS feeds
    Discuss on Forum Discuss on Forum
    share this page with others

    Article Dates:

    calendar icon Modified: 7/2/2008 calendar icon Created: 9/12/2003
Current Sponsors
About Virtualmedicalcentre.com

Virtual Medical Centre

Australia’s leading source for trustworthy medical information written by health professionals.

Please be aware that we do not give advice on your individual medical condition,
if you want advice please see your treating physician.

Virtual Medical Centre © 2002 - 2013 | Privacy Policy Last updated 20 May 2013

Parenting information is available at Parenthub.com.au

^ Back to Top
 
Partners and Accreditations
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.
Health insite MindHealth Connect Pregnancy Birth and Baby
PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance Parenthub.com.au for parenting information
For banner advertising
Multi Channel Network
Website and videos by
Titan Web
Titan Web Clients
Web Design Perth